196 related articles for article (PubMed ID: 2673787)
1. Transfection of EK-3, a subline of NIH 3T3, with the oncogene Ha-ras does not abolish its anchorage dependence.
Katz E; Samid D
Eur J Cell Biol; 1989 Aug; 49(2):221-4. PubMed ID: 2673787
[TBL] [Abstract][Full Text] [Related]
2. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
Endlich B; Salavati R; Sullivan T; Ling CC
Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
[TBL] [Abstract][Full Text] [Related]
3. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
4. [A study on reversion of the human activated c-Ha-ras-transformed cells].
Ogiso Y
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
[TBL] [Abstract][Full Text] [Related]
5. A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation.
Katz E; Carter BJ
J Natl Cancer Inst; 1986 Oct; 77(4):909-14. PubMed ID: 3463820
[TBL] [Abstract][Full Text] [Related]
6. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.
Sugimoto Y; Ikawa Y; Nakauchi H
Cancer Res; 1991 Jan; 51(1):99-104. PubMed ID: 1670996
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch PC; Ritter M; Häussinger D; Lang F
Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
9. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
Denner J; Ehm I; Jandrig B; Friese D
Arch Geschwulstforsch; 1987; 57(6):463-74. PubMed ID: 3435225
[TBL] [Abstract][Full Text] [Related]
10. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
11. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line.
Katz E; Carter BJ
Cancer Res; 1986 Jun; 46(6):3023-6. PubMed ID: 3009007
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the human Harvey-ras oncogene expression by DNA methylation.
Borrello MG; Pierotti MA; Donghi R; Bongarzone I; Cattadori MR; Traversari C; Mondellini P; Della Porta G
Oncogene Res; 1988; 2(2):197-203. PubMed ID: 2464152
[TBL] [Abstract][Full Text] [Related]
13. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
Takahashi N; De Luca LM; Breitman TR
Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
[TBL] [Abstract][Full Text] [Related]
14. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
Shumaker DK; Sklar MD; Prochownik EV; Varani J
Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
[TBL] [Abstract][Full Text] [Related]
15. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
Weyman CM; Taparowsky EJ; Wolfson M; Ashendel CL
Cancer Res; 1988 Nov; 48(22):6535-41. PubMed ID: 3052806
[TBL] [Abstract][Full Text] [Related]
16. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
[TBL] [Abstract][Full Text] [Related]
17. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in transformation efficiency of NIH 3T3 cells as determined by transfection with oncogenes.
Katz E
Eur J Cell Biol; 1986 Dec; 42(2):231-5. PubMed ID: 3816817
[TBL] [Abstract][Full Text] [Related]
19. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
[TBL] [Abstract][Full Text] [Related]
20. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
Houck KA; Michalopoulos GK; Strom SC
Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
